Exclusive: Astellas partners with Boston ‘miniproteins’ startup

Chris Bahl believes AI can help make tiny proteins capable of doing things that bigger and more traditional proteins like antibodies struggle to do. And now the Japanese drugmaker Astellas is buying into his vision ...